Cipla

Cipla Launches AI-Powered Mobile App for Asthma Screening December 19, 2024 Cipla unveils CipAir, an AI-powered mobile application integrated with the Breathefree platform, enabling first-line asthma screening. Clinically validated and accessible via Android, the app uses advanced acoustic analysis to provide personalised results, aiming to empower users with timely health insights and resources.

Cipla, Alkem Lead Race to Acquire Sahajanand Medical Technologies October 17, 2024 Cipla and Alkem Laboratories are leading candidates to acquire a majority stake in SMT, with the company considering an IPO if valuation targets are unmet.

Samina Hamie Steps Down from Cipla Board Amid Shuffling Drive July 29, 2024 Effective from October 29, 2024, Hamied’s resignation follows her earlier exit from the company's executive role in January.

Cipla to Invest Additional INR 26 Cr in Achira Labs May 17, 2024 Upon the completion of the first tranche of the new investment, Cipla’s stake in Achira Labs will increase to 27.27% of the total voting rights.

Cipla Promoters to Offload 2.5% Stake at INR 2,650 Cr May 16, 2024 Promoters Yusuf Khwaja Hamied and Mustafa Khwaja Hamied plan to sell the stake to institutional investors, potentially generating up to INR 1,849 Cr

Dr Reddy's, Cipla, Glenmark, Biocon, & Wockhardt Grabbed INR 25,813 Cr under PLI Schemes April 1, 2024 The PLI schemes, with an INR 1.97 Lakh Cr outlay across 14 sectors, aim to boost investments, drive innovation, and improve competitiveness in key industries.

Cipla Partners Kemwell & Manipal for Global Cell Therapy Advancements January 9, 2024 Global pharmaceutical company Cipla has joined hands with Kemwell Biopharma and Manipal Education & Medical Group in the US. The joint venture seeks to expedite the development, manufacturing, and distribution of cell therapies.

Top Acquisitions that Hit The Pharma Industry in 2023 December 28, 2023 At the heart of this transformative journey were the noteworthy acquisitions that left an indelible mark on the pharma landscape. Let's take a closer look at some of the top acquisitions that shaped the pharma sector in 2023.

Cipla Invests Additional $5.04 Mn in GoApptiv to Enhance Digital Healthcare Access December 19, 2023 The journey began in June 2020 when Cipla initially acquired a 21.85% stake in GoApptiv for INR 9 Cr. Over the following two years, Cipla progressively increased its stake to 22.02%, investing INR 25.90 Cr.

Torrent Pharmaceuticals Secures $5 Bn Funds for Cipla Deal October 23, 2023 Indian pharmaceutical major, Torrent Pharmaceuticals has lined up at least $5 billion in funding to take over its rival Cipla Ltd.

Cipla Stake Sale Plan Faces Indecision Amidst Valuation Disagreements October 10, 2023 The ongoing buzz surrounding the Cipla acquisition has taken a new turn, with promoters disagreements on the company's valuation figure.

Cipla Foundation, NIMHANS Partners to Set Up Neuro-Palliative Care Unit October 5, 2023 In partnership with the Cipla Foundation, the National Institute of Mental Health and Neuro-Sciences (NIMHANS) has launched a neuro-palliative care unit in Bengaluru.